A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that GW427353, a beta-3 adrenergic agonist, retards the
emptying of the colon and increases total colonic transit time.